Nilesh Deshpande - Concepedia

Author

Nilesh Deshpande

Also Known As

N. Deshpande, Nilay Deshpande, Nilesh Deshpande, Nilesh U Deshpande, Nilesh U. Deshpande, Nilesh Umakant Deshpande, Nilkanth Deshpande, Shripad Banawali

128

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Tata Memorial Hospital Advanced Centre for Treatment, Research and Education in Cancer Homi Bhabha National Institute Indian Institute of Science Education and Research Pune HCG Cancer Hospital

About

Nilesh Deshpande is an author at Tata Memorial Hospital specializing in biomolecular engineering, medicine, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	5	5	210
2	Medicine	5	5	206
3	Biomolecular Engineering	5	5	210
4	Biology	1	1	63
5	Biomedical Engineering	1	1	48

Nilesh Deshpande

Publications

999

Citations

H-Index

Page 1

	Year	Citations
Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer Anna Bianchi, Iago De Castro Silva, Nilesh Deshpande, Cancer Discovery	2023	116
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML) Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh, Leukemia	2021	92
A High‐Sensitivity 10‐Color Flow Cytometric Minimal Residual Disease Assay in B‐Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2‐in‐10<sup>6</sup>and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients Prashant Tembhare, Papagudi Ganesan Subramanian, Sitaram Ghogale, Cytometry Part B Clinical Cytometry	2019	74
Biotin-Tagged Polysaccharide Vesicular Nanocarriers for Receptor-Mediated Anticancer Drug Delivery in Cancer Cells Nilesh Deshpande, M. Jayakannan Biomacromolecules	2018	64
ESTExplorer: an expressed sequence tag (EST) assembly and annotation platform Shivashankar H. Nagaraj, Nilesh Deshpande, Robin B. Gasser, Nucleic Acids Research EngineeringMolecular BiologyGenomicsSequence AlignmentBioinformatics Database	2007	63
Evaluation of new markers for minimal residual disease monitoring in B‐cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000–000 Prashant Tembhare, Sitaram Ghogale, Nisha Ghatwai, Cytometry Part B Clinical Cytometry	2016	63
Cisplatin-Stitched Polysaccharide Vesicles for Synergistic Cancer Therapy of Triple Antagonistic Drugs Nilesh Deshpande, M. Jayakannan Biomacromolecules Cisplatin-stitched Polysaccharide NanovesiclesNanotherapeuticsEngineeringTriple Antagonistic DrugsProtein Nanoparticles	2016	51
An AIE-driven fluorescent polysaccharide polymersome as an enzyme-responsive FRET nanoprobe to study the real-time delivery aspects in live cells Nilesh Deshpande, Mishika Virmani, M. Jayakannan Polymer Chemistry Biofunctional MaterialNanomedicineEnzyme-responsive Fret NanoprobeCell-based Drug DeliveryLive Cancer Cells	2020	48
Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer Jashodeep Datta, Anna Bianchi, Iago De Castro Silva, Oncogene Distinct MechanismsCancer ImmunosurveillancePancreatic CancerMedicineImmunology	2022	44
Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy Prashant Tembhare, Harshini Sriram, Twinkle Khanka, Journal for ImmunoTherapy of Cancer	2020	41

Page 1